RNAZ TRANSCODE THERAPEUTICS INC Investments/Divestments 8-K Filing 2023 - Securities Purchase Agreement Transcode Therapeutics, Inc. entered into a Securities Purchase Agreement for a public offering of 2,000,000 shares of common stock and accompanying warrants for gross proceeds of $7.0 million.Get access to all SEC 8-K filings of the TRANSCODE THERAPEUTICS INC